Regulation of proapoptotic proteins Bak1 and p53 by miR-125b in an experimental model of Alzheimer's disease: Protective role of 17β-estradiol

Neuroscience Letters

Volumn 629, Issue , 2016, Pages 234-240

  Micheli, F ^a   Palermo, R ^c   Talora, C ^a   Ferretti, E ^b   Vacca, A ^b   Napolitano, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

17 Estradiol; Alzheimer disease; mir 125b

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; MICRORNA 125B; PROTEIN BAK; PROTEIN BAK1; PROTEIN P53; UNCLASSIFIED DRUG; AMYLOID BETA-PROTEIN (25-35); BAK1 PROTEIN, MOUSE; MICRORNA; MIRN125 MICRORNA, MOUSE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ESTRADIOL; MICE; MICE, INBRED C57BL; MICRORNAS; NEURONS; PEPTIDE FRAGMENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84978886835     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.05.049     Document Type: Article

References (35)

1. [1] Alexandrov, P.N., Zhao, Y., Jones, B.M., Bhattacharjee, S., Lukiw, W.J., MicroRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3 (2012), 365–373.
2. [3] Ardekani, A.M., Naeini, M.M., The role of microRNAs in human diseases. Avicenna J. Med. Biotechnol. 2 (2010), 161–179.
3. [4] Blennow, K., de Leon, M.J., Zetterberg, H., Alzheimer's disease. Lancet 368 (2006), 387–403.
4. [5] Culmsee, C., Zhu, X., Yu, Q.S., Chan, S.L., Camandola, S., Guo, Z., Greig, N.H., Mattson, M.P., A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77 (2001), 220–228.
5. [6] de la Monte, S.M., Sohn, Y.K., Wands, J.R., Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152 (1997), 73–83.
6. [7] Delay, C., Hebert, S.S., MicroRNAs and alzheimer's disease mouse models: current insights and future research avenues. Int. J. Alzheimers Dis., 2011, 894938.
7. [8] Esquela-Kerscher, A., Slack, F.J., Oncomirs—microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006), 259–269.
8. [9] Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P.R., Rimmer, E., Scazufca, M., Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005), 2112–2117.
9. [10] Green, P.S., Bishop, J., Simpkins, J.W., 17 Alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17 (1997), 511–515.
10. [11] Hauw, J.J., Seilhean, D., Piette, F., Uchihara, T., Duyckaerts, C., Alzheimer's disease lesions: from morphology to cell biology. Bull. Acad. Natl. Med. 180 (1996), 1687–1700.
11. [12] Hebert, S.S., De Strooper, B., Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 32 (2009), 199–206.
12. [13] Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M.A., Perry, G., Whitehouse, P.J., Taniguchi, T., Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780 (1998), 260–269.
13. [14] Klinge, C.M., miRNAs and estrogen action. Trends Endocrinol. Metab. 23 (2012), 223–233.
14. [15] Krajewski, S., Krajewska, M., Reed, J.C., Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res. 56 (1996), 2849–2855.
15. [16] Kumar, V., Palermo, R., Talora, C., Campese, A.F., Checquolo, S., Bellavia, D., Tottone, L., Testa, G., Miele, E., Indraccolo, S., Amadori, A., Ferretti, E., Gulino, A., Vacca, A., Screpanti, I., Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 28 (2014), 2324–2335.
16. [17] Lau, P., Bossers, K., Janky, R., Salta, E., Frigerio, C.S., Barbash, S., Rothman, R., Sierksma, A.S., Thathiah, A., Greenberg, D., Papadopoulou, A.S., Achsel, T., Ayoubi, T., Soreq, H., Verhaagen, J., Swaab, D.F., Aerts, S., De Strooper, B., Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol. Med. 5 (2013), 1613–1634.
17. [18] Le, M.T., Shyh-Chang, N., Khaw, S.L., Chin, L., Teh, C., Tay, J., O'Day, E., Korzh, V., Yang, H., Lal, A., Lieberman, J., Lodish, H.F., Lim, B., Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet., 7, 2011, e1002242.
18. [19] Le, M.T., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H.F., Lim, B., MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23 (2009), 862–876.
19. [20] Le, M.T., Xie, H., Zhou, B., Chia, P.H., Rizk, P., Um, M., Udolph, G., Yang, H., Lim, B., Lodish, H.F., MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell Biol. 29 (2009), 5290–5305.
20. [21] Li, Y.Y., Cui, J.G., Hill, J.M., Bhattacharjee, S., Zhao, Y., Lukiw, W.J., Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci. Lett. 487 (2011), 94–98.
21. [23] Manca, S., Magrelli, A., Cialfi, S., Lefort, K., Ambra, R., Alimandi, M., Biolcati, G., Uccelletti, D., Palleschi, C., Screpanti, I., Candi, E., Melino, G., Salvatore, M., Taruscio, D., Talora, C., Oxidative stress activation of miR-125b is part of the molecular switch for Hailey–Hailey disease manifestation. Exp. Dermatol. 20 (2011), 932–937.
22. [24] Napolitano, M., Costa, L., Palermo, R., Giovenco, A., Vacca, A., Gulino, A., Protective effect of pioglitazone, a PPARgamma ligand, in a 3 nitropropionic acid model of Huntington's disease. Brain Res. Bull. 85 (2011), 231–237.
23. [25] Napolitano, M., Costa, L., Piacentini, R., Grassi, C., Lanzone, A., Gulino, A., 17beta-estradiol protects cerebellar granule cells against beta-amyloid-induced toxicity via the apoptotic mitochondrial pathway. Neurosci. Lett. 561 (2014), 134–139.
24. [26] Palermo, R., Checquolo, S., Giovenco, A., Grazioli, P., Kumar, V., Campese, A.F., Giorgi, A., Napolitano, M., Canettieri, G., Ferrara, G., Schininà, M.E., Maroder, M., Frati, L., Gulino, A., Vacca, A., Screpanti, I., Acetylation controls Notch3 stability and function in T-cell leukemia. Oncogene 31 (2012), 3807–3817.
25. [27] Pike, C.J., Carroll, J.C., Rosario, E.R., Barron, A.M., Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 30 (2009), 239–258.
26. [28] Schonrock, N., Ke, Y.D., Humphreys, D., Staufenbiel, M., Ittner, L.M., Preiss, T., Götz, J., Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One, 5(6), 2010, e11070.
27. [29] Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., Ambros, V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol., 5, 2004, R13.
28. [30] Sethi, P., Lukiw, W.J., Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 459:2 (2009), 100–104.
29. [31] Shao, N.Y., Hu, H.Y., Yan, Z., Xu, Y., Hu, H., Menzel, C., Li, N., Chen, W., Khaitovich, P., Comprehensive survey of human brain microRNA by deep sequencing. BMC Genomics, 11, 2010, 409.
30. [32] Shi, X.B., Xue, L., Yang, J., Ma, A.H., Zhao, J., Xu, M., Tepper, C.G., Evans, C.P., Kung, H.J., deVere White, R.W., An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 19983–19988.
31. [33] Thangnipon, W., Puangmalai, N., Chinchalongporn, V., Jantrachotechatchawan, C., Kitiyanant, N., Soi-Ampornkul, R., Tuchinda, P., Nobsathian, S., N-Benzylcinnamide protects rat cultured cortical neurons from beta-amyloid peptide-induced neurotoxicity. Neurosci. Lett. 556 (2013), 20–25.
32. [34] Thangnipon, W., Suwanna, N., Kitiyanant, N., Soi-Ampornkul, R., Tuchinda, P., Munyoo, B., Nobsathian, S., Protective role of N-trans-feruloyltyramine against beta-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons. Neurosci. Lett. 513 (2012), 229–232.
33. [35] Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., Qin, C., miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80 (2009), 268–273.
34. [36] Wechsler-Reya, R.J., Scott, M.P., Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22 (1999), 103–114.
35. [37] Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., Xiong, W., Li, G., Lu, J., Fodstad, O., Riker, A. I, Tan, M., MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J. Biol. Chem. 285 (2010), 21496–21507.